pcos-2018-posters-accepted-abstracts

19 / 25

PCOS 2018 Journal of Clinical and Molecular Endocrinology
ISSN: 2572-5432 Page 47
June 07-08, 2018
London, UK
4th World Congress on
Polycystic Ovarian
Syndrome
Background: Young adult females with chronic pelvic pains (CPP)
refractory to conventional medical therapy are still a big dilemma
for gynecologists.
Study Objective: To study the prevalence and clinical
manifestations of endometriosis in young adult females with CPP
refractory to conventional medical therapy.
Materials & Methods: Design: Prospective clinical study. Setting:
General and private hospitals in the city of Al-Karak/Jordan.
Participants: A total of 28 females aged ≤21 years who had
CPP refractory to conventional medical therapy and underwent
laparoscopy during the years 2010–2014 were identified for
this study. Endometriosis was staged according to the American
Society for Reproductive Medicine (ASRM) classification.
Results: The mean age of participants was 18.4 years (range
15–21). Endometriosis was found in 20/28 cases (71.4%). Stage
I: 9/20 (45.0%). stage II: 8/20 (40%), stage III: 2/21 (10%), stage
IV: 1/21 (5%). Notably, 16/28 (57.1%) of all cases reported cold
intolerance, 14/20 (70%) with endometriosis and 2/8 (25%) of
those without endometriosis (Chi-square 4.725, df-1, p-0.03).
There was no association between stage of disease with age
distribution (≤18 and >19–21 years) p=0.700 nor with duration of
symptoms (≤2 and >2 years) and the presence of cold intolerance
p >0.05. However, severity of pain symptoms (<7 vs ≥7) was
associated significantly with the stage of the disease p=0.011.
Conclusions: High prevalence of endometriosis among young
adult females with CPP refractory to conventional therapy was
mainly observed in the mild stage. Cold intolerances were highly
associated with endometriosis.
Prevalence of endometriosis and its symptoms among
young adult females with chronic pelvic pain refractory to
conventional therapy
Moamar Al-Jefout1, 2, Nedal Alnawaiseh1, Samer Yaghi1 and Ameen Alqaisi1
1Mutah University, Jordan
2United Arab Emirates University, UAE
J Clin Mol Endocrinol 2018, Volume 3
DOI: 10.21767/2572-5432-C1-003